| 1 |
Kaya Akyüzlü D. Buprenorfin Farmakokinetiğinde ve Farmakodinamiğinde Rol Oynayan Gen Polimorfizmleri: Genel Bakış. Bağımlılık Dergisi 2023;24:1-1. [DOI: 10.51982/bagimli.1203151] [Reference Citation Analysis]
|
| 2 |
Pollard AA, Hauson AO, Lackey NS, Zhang E, Khayat S, Carson B, Fortea L, Radua J, Grant I. Functional neuroanatomy of craving in heroin use disorder: voxel-based meta-analysis of functional magnetic resonance imaging (fMRI) drug cue reactivity studies. Am J Drug Alcohol Abuse 2023;:1-13. [PMID: 36880845 DOI: 10.1080/00952990.2023.2172423] [Reference Citation Analysis]
|
| 3 |
Wang Y, Hou X, Wei S, Yan J, Chen Z, Zhang M, Zhang Q, Lu Y, Zhang Q, Zheng T, Jia J, Dong B, Li Y, Zhang Y, Liang J, Li G. The roles of ubiquitin-proteasome system and regulator of G protein signaling 4 in behavioral sensitization induced by a single morphine exposure. Brain Behav 2023;13:e2922. [PMID: 36793204 DOI: 10.1002/brb3.2922] [Reference Citation Analysis]
|
| 4 |
Darharaj M, Hekmati I, Mohammad Ghezel Ayagh F, Ahmadi A, Eskin M, Abdollahpour Ranjbar H. Emotional Dysregulation and Craving in Patients with Substance Use Disorder: the Mediating Role of Psychological Distress. Int J Ment Health Addiction 2023. [DOI: 10.1007/s11469-023-01031-z] [Reference Citation Analysis]
|
| 5 |
Lu L, Yang W, Zhao D, Wen X, Liu J, Liu J, Yuan K. Brain recovery of the NAc fibers and prediction of craving changes in person with heroin addiction: A longitudinal study. Drug Alcohol Depend 2023;243:109749. [PMID: 36565569 DOI: 10.1016/j.drugalcdep.2022.109749] [Reference Citation Analysis]
|
| 6 |
Sirvent-Ruiz CM, Moral-Jiménez MV, Herrero J, Miranda-Rovés M, Rodríguez Díaz FJ. Concept of Affective Dependence and Validation of an Affective Dependence Scale. Psychol Res Behav Manag 2022;15:3875-88. [PMID: 36605173 DOI: 10.2147/PRBM.S385807] [Reference Citation Analysis]
|
| 7 |
Elrassas HH, Morsy MH, Abdelrazek YM, El Rasheed AH, Saad NA, Azzam LA. The role of repetitive transcranial magnetic stimulation in reduction of opioid craving: a single-blinded randomized sham-controlled clinical trial. Middle East Curr Psychiatry 2022;29:106. [DOI: 10.1186/s43045-022-00265-2] [Reference Citation Analysis]
|
| 8 |
Kelley AT, Incze MA, Baylis JD, Calder SG, Weiner SJ, Zickmund SL, Jones AL, Vanneman ME, Conroy MB, Gordon AJ, Bridges JFP. Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice. Subst Abus 2022;43:1286-99. [PMID: 35849749 DOI: 10.1080/08897077.2022.2095082] [Reference Citation Analysis]
|
| 9 |
Samson KR, Xu W, Kortagere S, España RA. Intermittent access to oxycodone decreases dopamine uptake in the nucleus accumbens core during abstinence. Addict Biol 2022;27:e13241. [PMID: 36301217 DOI: 10.1111/adb.13241] [Reference Citation Analysis]
|
| 10 |
Bhoora U, Gloeck NR, Scheibe A. Managing acute opioid withdrawal with tramadol during COVID-19 lockdown in a peri-urban setting. African Journal of Primary Health Care & Family Medicine 2022;14. [DOI: 10.4102/phcfm.v14i1.3386] [Reference Citation Analysis]
|
| 11 |
Compton WM, Wargo EM, Volkow ND. Neuropsychiatric Model of Addiction Simplified. Psychiatr Clin North Am 2022;45:321-34. [PMID: 36055726 DOI: 10.1016/j.psc.2022.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Ellis JD, Mun CJ, Epstein DH, Phillips KA, Finan PH, Preston KL. Intra-individual variability and stability of affect and craving among individuals receiving medication treatment for opioid use disorder. Neuropsychopharmacology 2022;47:1836-43. [PMID: 35668168 DOI: 10.1038/s41386-022-01352-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Parikh A, Moeller SJ, Garland EL. Simulated opioid choice linked to opioid use disorder severity among veterans with chronic pain: initial validation of a novel paradigm. The American Journal of Drug and Alcohol Abuse 2022;48:403-412. [DOI: 10.1080/00952990.2021.2007258] [Reference Citation Analysis]
|
| 14 |
Biernacki K, Lopez-Guzman S, Messinger JC, Banavar NV, Rotrosen J, Glimcher PW, Konova AB. A neuroeconomic signature of opioid craving: How fluctuations in craving bias drug-related and nondrug-related value. Neuropsychopharmacology 2022;47:1440-8. [PMID: 34916590 DOI: 10.1038/s41386-021-01248-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Mcdermott-winger ER, Latham CL. Medications for Opioid Use Disorder During Incarceration. UJAN 2022;33:182-190. [DOI: 10.1097/jan.0000000000000482] [Reference Citation Analysis]
|
| 16 |
Lamey PS, Landis DM, Nugent KM. Iatrogenic opioid withdrawal syndromes in adults in intensive care units: a narrative review. J Thorac Dis 2022;14:2297-308. [PMID: 35813766 DOI: 10.21037/jtd-22-157] [Reference Citation Analysis]
|
| 17 |
Khatri UG, Lee K, Lin T, D’orazio JL, Patel MS, Shofer FS, Perrone J. A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD). J Med Toxicol . [DOI: 10.1007/s13181-022-00890-7] [Reference Citation Analysis]
|
| 18 |
Varshney U, Bourgeois AG, Singh N, Dube SR. SCCORe: Smart Continuity of Care for Opioid Recovery. 2022 Wireless Telecommunications Symposium (WTS) 2022. [DOI: 10.1109/wts53620.2022.9768318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Parisi A, Landicho HL, Hudak J, Leknes S, Froeliger B, Garland EL. Emotional distress and pain catastrophizing predict cue-elicited opioid craving among chronic pain patients on long-term opioid therapy. Drug Alcohol Depend 2022;233:109361. [PMID: 35278786 DOI: 10.1016/j.drugalcdep.2022.109361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 20 |
Florence L, Lassi DLS, Kortas GT, Lima DR, de Azevedo-marques Périco C, Andrade AG, Torales J, Ventriglio A, De Berardis D, De Aquino JP, Castaldelli-maia JM. Brain Correlates of the Alcohol Use Disorder Pharmacotherapy Response: A Systematic Review of Neuroimaging Studies. Brain Sciences 2022;12:386. [DOI: 10.3390/brainsci12030386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Shojaati N, Osgood ND. Dynamic Computational Models and Simulations of the Opioid Crisis: A Comprehensive Survey. ACM Trans Comput Healthcare 2022;3:1-25. [DOI: 10.1145/3469658] [Reference Citation Analysis]
|
| 22 |
Kiguchi N, Ko M. Potential therapeutic targets for the treatment of opioid abuse and pain. Behavioral Pharmacology of Drug Abuse: Current Status 2022. [DOI: 10.1016/bs.apha.2021.09.002] [Reference Citation Analysis]
|
| 23 |
Zhou WR, Wang YM, Wang M, Wang ZL, Zheng H, Wang MJ, Potenza MN, Dong GH. Connectome-based prediction of craving for gaming in internet gaming disorder. Addict Biol 2022;27:e13076. [PMID: 34176197 DOI: 10.1111/adb.13076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Verzijl CL, Gius B, Schlauch R, Rancourt D. The transdiagnostic role of food craving: An application of substance use models. Appetite 2021;:105867. [PMID: 34915105 DOI: 10.1016/j.appet.2021.105867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 25 |
Boyett B, Wiest K, McLeod LD, Nelson LM, Bickel WK, Learned SM, Heidbreder C, Fudala PJ, Le Moigne A, Zhao Y. Assessment of craving in opioid use disorder: Psychometric evaluation and predictive validity of the opioid craving VAS. Drug Alcohol Depend 2021;229:109057. [PMID: 34794061 DOI: 10.1016/j.drugalcdep.2021.109057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 26 |
Ghantous Z, Ahmad V, Khoury R. Illicit Drug Use in Older Adults: An Invisible Epidemic? Clin Geriatr Med 2022;38:39-53. [PMID: 34794702 DOI: 10.1016/j.cger.2021.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 27 |
Zamboni L, Centoni F, Fusina F, Mantovani E, Rubino F, Lugoboni F, Federico A. The Effectiveness of Cognitive Behavioral Therapy Techniques for the Treatment of Substance Use Disorders: A Narrative Review of Evidence. J Nerv Ment Dis 2021;209:835-45. [PMID: 34698698 DOI: 10.1097/NMD.0000000000001381] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 28 |
Schellekens AFA, Veldman SE, Suranto ESD, van Rijswijk SM, van der Wal SEI, Schene AH, van Beek MHCT. Beneficial Effects of Opioid Rotation to Buprenorphine/Naloxone on Opioid Misuse, Craving, Mental Health, and Pain Control in Chronic Non-Cancer Pain Patients with Opioid Use Disorder. J Clin Med 2021;10:3727. [PMID: 34442024 DOI: 10.3390/jcm10163727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 29 |
Zhang J, Chen S, Jiang Q, Dong H, Zhao Z, Du X, Dong GH. Disturbed craving regulation to gaming cues in internet gaming disorder: Implications for uncontrolled gaming behaviors. J Psychiatr Res 2021;140:250-9. [PMID: 34119910 DOI: 10.1016/j.jpsychires.2021.05.051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 30 |
Bruneau A, Frimerman L, Verner M, Sirois A, Fournier C, Scott K, Perez J, Shir Y, Martel MO. Day-to-day opioid withdrawal symptoms, psychological distress, and opioid craving in patients with chronic pain prescribed opioid therapy. Drug Alcohol Depend 2021;225:108787. [PMID: 34091157 DOI: 10.1016/j.drugalcdep.2021.108787] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 31 |
Martel MO, Bruneau A, Edwards RR. Mind-body approaches targeting the psychological aspects of opioid use problems in patients with chronic pain: evidence and opportunities. Transl Res 2021;234:114-28. [PMID: 33676035 DOI: 10.1016/j.trsl.2021.02.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 32 |
Frasca DJ. Mindfulness: Principles and Application to Decrease Opiate Use in Primary Care With an Osteopathic Component. OFP 2021. [DOI: 10.33181/13023] [Reference Citation Analysis]
|
| 33 |
Bergeria CL, Strickland JC, Huhn AS, Strain EC, Dunn KE. A preliminary examination of the multiple dimensions of opioid craving. Drug Alcohol Depend 2021;219:108473. [PMID: 33429294 DOI: 10.1016/j.drugalcdep.2020.108473] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 34 |
Ding H, Ko MC. Translational value of non-human primates in opioid research. Exp Neurol 2021;338:113602. [PMID: 33453211 DOI: 10.1016/j.expneurol.2021.113602] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 35 |
Lueptow LM, Shashkova EC, Miller MG, Evans CJ, Cahill CM. Insights into the Neurobiology of Craving in Opioid Use Disorder. Curr Anesthesiol Rep 2020;10:378-87. [PMID: 33424457 DOI: 10.1007/s40140-020-00420-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 36 |
Reichert RA, Silveira KM, Lopes FM, De Micheli D. Drug Abuse: Classifications, Effects and Risks. Behavior Analysis and Substance Dependence 2021. [DOI: 10.1007/978-3-030-75961-2_1] [Reference Citation Analysis]
|
| 37 |
Li W, Huang J, Zhang N, Weidacker K, Li J, Voon V, Wang C, Zhang C. Modulation of Attentional Bias to Drug and Affective Cues by Therapeutic and Neuropsychological Factors in Patients With Opioid Use Disorder on Methadone Maintenance Therapy. Front Psychiatry 2021;12:780208. [PMID: 35095598 DOI: 10.3389/fpsyt.2021.780208] [Reference Citation Analysis]
|
| 38 |
Zheng R, Hao L, Li Y, Zhang T, Bai D, Zhang L, Li D, Hao W. Commentary: Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice. Front Psychiatry 2021;12:615921. [PMID: 34434123 DOI: 10.3389/fpsyt.2021.615921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 39 |
Bertin C, Delage N, Rolland B, Pennel L, Fatseas M, Trouvin AP, Delorme J, Chenaf C, Authier N. Analgesic opioid use disorders in patients with chronic non-cancer pain: A holistic approach for tailored management. Neurosci Biobehav Rev 2021;121:160-74. [PMID: 33358994 DOI: 10.1016/j.neubiorev.2020.12.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 40 |
Abbaszadeh-Mashkani S, Hoque SS, Banafshe HR, Ghaderi A. The effect of crocin (the main active saffron constituent) on the cognitive functions, craving, and withdrawal syndrome in opioid patients under methadone maintenance treatment. Phytother Res 2021;35:1486-94. [PMID: 33078480 DOI: 10.1002/ptr.6913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 41 |
Gong H, Zhang Y, Ren Q, Zhou Z, Zhou H, Sun X, Zhang C, Voon V, Zhao M, Yu S. The Chinese version of obsessive compulsive drug use scale: validation in outpatient methadone maintenance treatment program. BMC Psychiatry 2020;20:465. [PMID: 32977774 DOI: 10.1186/s12888-020-02843-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 42 |
Elman I, Howard M, Borodovsky JT, Mysels D, Rott D, Borsook D, Albanese M. Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone. Sci Rep 2020;10:5617. [PMID: 32221389 DOI: 10.1038/s41598-020-62556-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 43 |
Arillotta D, Schifano F, Napoletano F, Zangani C, Gilgar L, Guirguis A, Corkery JM, Aguglia E, Vento A. Novel Opioids: Systematic Web Crawling Within the e-Psychonauts' Scenario. Front Neurosci 2020;14:149. [PMID: 32256304 DOI: 10.3389/fnins.2020.00149] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 44 |
Balandeh E, Omidi A, Ghaderi A. A Narrative Review of Third-Wave Cognitive-Behavioral Therapies in Addiction. Addict Health 2021;13:52-65. [PMID: 33995960 DOI: 10.22122/ahj.v13i1.298] [Reference Citation Analysis]
|
